What to Record in a Tesamorelin Research Log After Reconstitution
A reference guide to the specific data points a tesamorelin research log should capture after reconstitution, from vial identifiers to concentration math.
Reviewed by Yuki Tanaka, PhD, molecular biologist ·
Yuki Tanaka, PhD is a molecular biologist with a doctorate from Osaka University and postdoctoral training at Stanford School of Medicine, specializing in growth hormone axis biology, GHRH receptor signaling, and synthetic peptide analog mechanisms.
A tesamorelin research log should record vial identity, reconstitution volume, resulting concentration, storage conditions, and a timestamp for every step from mixing to disposal. The goal of the log is traceability: anyone reviewing the record later should be able to reconstruct exactly what was mixed, at what concentration, and how it was handled, without relying on memory. This matters because tesamorelin, like most lyophilized peptides, changes from a stable powder to a much less stable solution the moment bacteriostatic water is added, and the record is the only thing that captures that transition accurately.
Vial and lot identification
The first entries in any log should identify the material itself, not just the action taken. This includes the vial’s labeled peptide content in milligrams, the lot or batch number printed on the vial or box, and the supplier name. If a certificate of analysis (COA) was provided with the batch, the log should note the COA’s own reference number or date, since suppliers sometimes issue more than one COA revision for the same lot. Recording this before reconstitution means the concentration math that follows is tied to a specific, identifiable unit of material rather than a generic assumption about vial size.
Diluent volume and the resulting concentration
The single most important calculation in the log is the relationship between diluent volume and final concentration. Concentration is simply the labeled peptide mass in the vial divided by the volume of bacteriostatic water added. Adding more diluent lowers the concentration; adding less raises it. Neither choice changes the total amount of peptide in the vial, only how much liquid it is distributed across.
A worked example: a vial labeled 5 mg reconstituted with 2 mL of bacteriostatic water produces a concentration of 5 mg ÷ 2 mL = 2.5 mg/mL. Converting to micrograms, since 1 mg equals 1000 mcg, that same solution holds 2500 mcg/mL. On a U-100 insulin syringe, where 1 mL corresponds to 100 unit markings, each unit line represents 1/100 of a milliliter, so each unit of that particular solution corresponds to 2500 mcg ÷ 100 = 25 mcg. A log entry that only says “reconstituted” without recording the diluent volume makes this entire chain of figures unrecoverable later.
| Vial label | Diluent added | Concentration (mg/mL) | Concentration (mcg/mL) | Per syringe unit (mcg) |
|---|---|---|---|---|
| 2 mg | 1 mL | 2.0 | 2000 | 20 |
| 5 mg | 2 mL | 2.5 | 2500 | 25 |
| 5 mg | 1 mL | 5.0 | 5000 | 50 |
| 10 mg | 2 mL | 5.0 | 5000 | 50 |
These figures are arithmetic outputs of the mg-per-mL relationship above, not manufacturer claims, and a log should show the calculation alongside the result so an error in one vial’s math doesn’t propagate silently into later entries.
Reconstitution technique and observations
Beyond the numbers, a thorough log records how the reconstitution was performed: whether the diluent was added slowly along the vial wall, whether the vial was swirled or left to sit rather than shaken, and how long it took for the lyophilized powder to fully dissolve. Cloudiness, discoloration, or visible particulate after mixing are worth recording as observations, since they describe what was seen rather than making any claim about whether the material is usable. Documenting the appearance immediately after mixing also gives a baseline to compare against on later inspection.
Storage conditions and timestamps
Once reconstituted, tesamorelin’s stability window depends heavily on temperature, so the log should record where the vial was stored (refrigerated, frozen, or at room temperature) and the exact date and time of reconstitution. Each time the vial is accessed afterward, noting the date of that access lets a reviewer calculate how long the solution has been in use. A log that records only the reconstitution date, without dates for subsequent withdrawals, makes it impossible to later determine how long a given draw had been sitting since mixing.
Withdrawal records
Every time solution is drawn from the vial, the log should capture the volume or unit amount withdrawn and the date. Over time, this creates a running total that can be checked against the original fill volume as a consistency check: if the sum of recorded withdrawals doesn’t match what should remain in the vial, that discrepancy is worth investigating before trusting later entries. This is also where a calculator tool can help keep the running arithmetic consistent, since manual subtraction across many entries is where transcription errors tend to accumulate; a dedicated reconstitution calculator can cross-check concentration and remaining-volume figures against the log.
Documentation cross-reference
A complete log links back to the source documentation for the material itself. For researchers comparing sourcing options, this tesamorelin listing illustrates the kind of documentation a log entry should reference: labeled peptide mass, lot number, and an associated COA. Recording which listing or supplier page the COA came from, alongside the vial’s own lot number, closes the loop between what the log says was mixed and what the paperwork says was purchased. Tying the log to a specific source page rather than a general supplier name also makes it easier to locate the exact COA again later if the supplier revises their catalog.
Why incomplete logs cause problems later
The GH/IGF-1 axis, which tesamorelin research is built around, is an area where downstream measurements are sensitive to timing and dose consistency across a study. A review of the GH/IGF-1 axis in ageing and longevity describes how variable this axis can be across even short time windows, which is one reason consistent, timestamped records of preparation and handling matter for any study design built around it. Separately, a review of the GH/IGF-1 axis in chronic heart failure illustrates how much downstream variability can appear from inconsistent preparation and handling conditions alone, independent of a peptide’s labeled purity. A research log that lacks concentration math, storage dates, or withdrawal records leaves no way to distinguish a genuine experimental variable from a documentation gap.
Summary
A tesamorelin research log earns its value by capturing five categories of information consistently: vial and lot identity, diluent volume with the resulting concentration calculation, reconstitution technique and appearance, storage conditions with timestamps, and a running withdrawal record. None of these entries require judgment calls about outcomes or effects; they are factual records of what was mixed, at what concentration, and when. A log built this way remains useful to anyone reviewing it later, regardless of who originally made the entries.
A note on how to read this
This article is written for research and educational reference. The materials described are sold for laboratory research and are not for human consumption. Nothing here is dosing guidance, a prescription, or a clinical recommendation.